PeopleBio, Inc. (KOSDAQ:304840)

South Korea · Delayed Price · Currency is KRW

857.00

-17.00 (-1.95%)

At close: Jul 22, 2026

-67.04% (1Y)

Market Cap	21.21B -61.5%
Revenue (ttm)	2.87B +19.2%
Net Income	-14.90B
EPS	-680.98
Shares Out	24.26M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,624,480
Open	839.00
Previous Close	874.00
Day's Range	760.00 - 1,108.00
52-Week Range	600.00 - 2,970.00
Beta	0.58
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About PeopleBio

PeopleBio, Inc., a biotech company, develops bioproducts for diagnostic and treatment of protein misfolding diseases. Its Multimer Detection System technology uses capturing antibodies and epitope-overlapping detection antibodies for the detection of oligomers or multimers from monomers in protein-misfolding diseases. PeopleBio, Inc. was founded in 2002 and is based in Seongnam-si, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances

Founded 2002

Employees 29

Stock Exchange KOSDAQ

Ticker Symbol 304840

Full Company Profile

Financial Performance

In 2025, PeopleBio's revenue was 2.85 billion, an increase of 12.64% compared to the previous year's 2.53 billion. Losses were -15.71 billion, 44.0% more than in 2024.

Financial Statements